Time to Thrombolytics and Tissue Salvage: Assessing Response Following Severe Frostbite Injury
Journal of Burn Care & Research · 2025
DOI: 10.1093/jbcr/iraf051 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Burn Care & Research, 2025. Verfasst von Rachel M Nygaard und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Hennepin County Medical Center, Hennepin Healthcare, Minneapolis, MN 55415, United States. Hauptthemen laut MEDLINE: Frostbite, Thrombolytic Therapy, Fibrinolytic Agents, Time-to-Treatment. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AHRQ HHS.
Abstract (Originalsprache)
Approximately 30% of severe frostbite injuries result in amputation. Thrombolytic therapy is used to reduce tissue loss following severe frostbite injury. This study evaluates factors impacting the effectiveness of thrombolytics using post-treatment perfusion imaging and amputation level as outcome measures. We hypothesize that categorizing thrombolytic-treated patients into full, partial, and nonresponders enable a nuanced evaluation of treatment effectiveness. A prospectively maintained frostbite database was reviewed for patients with post-rewarming perfusion deficits measured by Tc99 scans who received IV thrombolytics. Of 131 patients, 71% were full responders, 23.7% were partial responders, and 5.3% were nonresponders for surgical outcome. The median time to thrombolytics was 5.5 h (range 1-14.5) for full responders; 7 h (range 3.5-14) for partial responders; and 10 h (range 1.5-11.5) for nonresponders. Full responders exhibited smaller initial perfusion deficits. Psychosocial or comorbid factors were not significantly different across groups. Nonresponse was associated with a longer time to thrombolytics, larger perfusion deficits, and cellulitis/infection. Using imaging outcomes to reduce confounding by infection, 93 patients were evaluated: 28% were full responders, 57% were partial responders, and 15% were nonresponders. Full responders for imaging outcomes corresponded with surgical outcomes and had no amputations, while 37.7% of partial responders and 42.9% of nonresponders on imaging outcomes had amputations. This study is the largest to evaluate thrombolytic outcomes in severe frostbite-injured patients, showing nearly 95% of patients improve after thrombolytic treatment for severe frostbite injury. This provides new insight into thrombolytic responses and a novel assessment of thrombolytic treatment efficacy. These findings underscore the importance of timely thrombolytic administration and demonstrate benefits for patients treated outside the standard thrombolytic treatment windows.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Hennepin County Medical Center, Hennepin Healthcare, Minneapolis, MN 55415, United States.
- Department of Radiology, Hennepin County Medical Center, Hennepin Healthcare, Minneapolis, MN 55415, United States.
ORCID-Profile: Rachel M Nygaard, Emily Colonna, Rediat A Tilahun, Charly Vang, Alexandra Lacey, Derek C Lumbard
Förderung
- AHRQ HHS
Zitieren
APA
Nygaard, R. M., Colonna, E., Tilahun, R. A., Vang, C., Punjabi, G., Lacey, A., Schmitz, K., & Lumbard, D. C. (2025). Time to Thrombolytics and Tissue Salvage: Assessing Response Following Severe Frostbite Injury. Journal of Burn Care & Research. https://doi.org/10.1093/jbcr/iraf051
Vancouver
Nygaard RM, Colonna E, Tilahun RA, Vang C, Punjabi G, Lacey A, et al. Time to Thrombolytics and Tissue Salvage: Assessing Response Following Severe Frostbite Injury. Journal of Burn Care & Research. 2025. doi:10.1093/jbcr/iraf051
BibTeX
@article{Nygaard2025,
author = {Nygaard, Rachel M and Colonna, Emily and Tilahun, Rediat A and Vang, Charly and Punjabi, Gopal and Lacey, Alexandra and Schmitz, Kyle and Lumbard, Derek C},
title = {Time to Thrombolytics and Tissue Salvage: Assessing Response Following Severe Frostbite Injury},
journal = {Journal of Burn Care & Research},
year = {2025},
doi = {10.1093/jbcr/iraf051}
}
EUVIMED